Biolipox Interim Report, January - March 2006.STOCKHOLM, Sweden -- Biolipox: --Revenues for the first quarter amounted to SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 11.1 million (0). --Earnings after tax amounted to SEK -16.8 million (-24.4) for the first quarter. --Earnings per share for the first quarter was SEK -23.66 (-30.77). --Cash-flow for the first quarter was positive and amounted to SEK 16.9 million (113.2). --Drug development projects advance according to plan Forthcoming financial information --Interim report, January - June 2006 29 August 2006 --Interim report, January - September 2006 19 October 2006 Biolipox's interim report for the first quarter 2006 is presented on the following pages. Biolipox is a research-intensive pharmaceutical company. The core of Biolipox's operations is world-leading research on arachidonic acid and its effects on inflammatory diseases - particularly asthma, chronic obstructive pulmonary disease chronic obstructive pulmonary disease n. Abbr. COPD A chronic lung disease, such as asthma or emphysema, in which breathing becomes slowed or forced. (COPD COPD chronic obstructive pulmonary disease. COPD abbr. chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) ), rhinitis Rhinitis Definition Rhinitis is inflammation of the mucous lining of the nose. Description Rhinitis is a nonspecific term that covers infections, allergies, and other disorders whose common feature is the location of their symptoms. , pain and arthritis. Through the in-house knowledge in the inflammatory research area, particularly arachidonic acid metabolism, Biolipox has created a portfolio of potential blockbusters in these therapeutic areas. The company has 40 employees and is owned by HealthCap, Apax Partners, Sofinnova Partners, SLS (Selective Laser Sintering) See laser sintering and 3D printing. Ventures, Credit Agricole Private Equity, Auriga Partners and the founders This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion